Related Experiment Video
Updated: Jun 10, 2026
09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Surrogate endpoints in randomized cardiovascular clinical trials.
Michael Domanski1, Stuart Pocock, Corine Bernaud
1The National Heart, Lung, and Blood Institute, Bethesda, MD 20892, USA.
Fundamental & Clinical Pharmacology
|August 12, 2010
Summary
Surrogate endpoints can speed up clinical trials by predicting clinical endpoints. Rigorous validation is essential to ensure surrogate endpoints accurately reflect treatment effects and guide trial progression.
Area of Science:
- Clinical trial methodology
- Biostatistics
- Pharmacometrics
Background:
- Surrogate endpoints predict clinical endpoints of interest (CEI).
- Using surrogate endpoints can significantly reduce trial duration and cost.
- Validation is crucial for reliable surrogate endpoint application.
Purpose of the Study:
- To discuss the applications of surrogate endpoints in clinical trials.
- To outline the necessity and methods for validating surrogate endpoints.
- To highlight the role of surrogate endpoints in Phase I, II, and III studies.
Main Methods:
- Review of surrogate endpoint principles and validation requirements.
- Discussion of surrogate endpoint utility across different trial phases.
- Emphasis on the importance of rigorous validation for inferring treatment effects.
Main Results:
- Surrogate endpoints offer a pathway to accelerate drug development.
- Validated surrogate endpoints provide confidence in treatment effect conclusions.
- Surrogate endpoints aid in decision-making for advancing to later-phase trials.
Conclusions:
- Surrogate endpoints are valuable tools for efficient clinical trial design.
- Rigorous validation ensures the integrity of surrogate endpoint use.
- Effective use of surrogate endpoints optimizes resource allocation in drug development.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
01:20Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...